A case report describes an 84-year-old man with chronic hepatitis B and a liver tumor. The patient received a combination of transarterial chemoembolization and lenvatinib. During the course of treatment, a mass was found in his tonsil area.
Testing of the tonsil mass revealed it was an undifferentiated carcinoma. Specific markers showed the tumor lost Hep Par-1 and Arginase-1, while keeping Glypican-3 and HSP70. The Ki-67 index was 80 percent. This finding suggests that liver cancer can spread to the head and neck region.
Because this is a single case report, the findings are not enough to change standard medical practices. However, it serves as a reminder for doctors to check for unusual lumps in the head or neck of patients with liver cancer. A multi-marker panel is recommended because losing one specific marker does not rule out a liver cancer spread.
Common questions
Can liver cancer spread to the throat or tonsils?
Yes, this case report describes a situation where an 84-year-old man with liver cancer had a tumor in his tonsil area. While this is a single case, it shows that liver cancer can spread to the head and neck. Doctors should look for unusual masses in these areas for patients with liver cancer.
What markers were found in the tonsil tumor?
The tonsil mass was tested using immunohistochemistry. It lost Hep Par-1 and Arginase-1, but it kept Glypican-3 and HSP70. The Ki-67 index was 80 percent. These tests help doctors identify the type of cancer and see if it spread from the liver.
Is this finding common for patients taking lenvatinib?
This information comes from a single case report and a literature review, not a large study. Because it is only one case, we cannot say how common this is for other patients. You should talk to your doctor about how these findings apply to your specific treatment plan.
